| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALZN | Common Stock | Purchase | $123K | +14K | +0.27% | $8.79* | 5.26M | Jun 25, 2021 | By Digital Power Lending, LLC | F1, F2 |
| transaction | ALZN | Common Stock | Purchase | $63.8K | +6.8K | +0.13% | $9.38* | 5.26M | Jun 28, 2021 | By Digital Power Lending, LLC | F2, F3 |
| transaction | ALZN | Common Stock | Purchase | $18.2K | +1.8K | +0.03% | $10.12* | 5.26M | Jun 28, 2021 | By Digital Power Lending, LLC | F2, F4 |
| transaction | ALZN | Common Stock | Purchase | $4.56K | +400 | +0.01% | $11.40* | 5.27M | Jun 28, 2021 | By Digital Power Lending, LLC | F2 |
| transaction | ALZN | Common Stock | Purchase | $12.8K | +1.3K | +0.02% | $9.83* | 5.27M | Jun 29, 2021 | By Digital Power Lending, LLC | F2, F5 |
| transaction | ALZN | Common Stock | Sale | -$3.02K | -300 | -0.01% | $10.06* | 5.27M | Jun 29, 2021 | By Digital Power Lending, LLC | F2, F6 |
| holding | ALZN | Common Stock | 15M | Jun 25, 2021 | By Ault Life Sciences, Inc. | F7 | |||||
| holding | ALZN | Common Stock | 10M | Jun 25, 2021 | By Ault Life Sciences Fund, LLC | F8 |
| Id | Content |
|---|---|
| F1 | The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $8.7876. The range of purchase prices on the transaction date was $8.64 to $9.08 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. |
| F2 | Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL. |
| F3 | The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $9.3766. The range of purchase prices on the transaction date was $8.80 to $9.75 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. |
| F4 | The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $10.1154. The range of purchase prices on the transaction date was $9.85 to $10.45 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. |
| F5 | The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $9.8339. The range of purchase prices on the transaction date was $9.57 to $10.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. |
| F6 | The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $10.0598. The range of sale prices on the transaction date was $10.01 to $10.17 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. |
| F7 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc. |
| F8 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC. |